Teladoc price target lowered to $14 from $16 at Jefferies Jefferies analyst Glen Santangelo lowered the firm's price target on Teladoc to $14 from $16 and keeps a Hold rating on the shares after updating the firm's model to reflect Q1 results and updated management commentary. The firm is moderating its outlook for the BetterHelp business given year-over-year comps that "continue to trend in the wrong direction," the analyst tells investors.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.